Analysed AURA BIOSCIENCES INC (AURA:NASDAQ) News Sources
Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion
04-05-2026
yahoo.com
Aura Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
04-05-2026
yahoo.com
Aura Biosciences Announces Pricing of $260 Million Public Offering of Common Stock and Pre-funded Warrants
04-05-2026
yahoo.com
Aura Biosciences Announces Closing of $299 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
05-05-2026
yahoo.com
Aura Biosciences Reports First Quarter 2026 Financial Results and Business Highlights
11-05-2026
yahoo.com
Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
19-05-2026
yahoo.com
Aura Biosciences Highlights Bel-Sar Eye Cancer Strategy, Mid-Year Bladder Data
20-05-2026
marketbeat.com
Aura Biosciences Gears Up for Bel-Sar Filing as Pivotal Eye Cancer Trial Advances
27-05-2026
marketbeat.com
What is the current price of AURA BIOSCIENCES INC (AURA:NASDAQ)?
The current price of AURA BIOSCIENCES INC (AURA:NASDAQ) is $6.28.
AURA BIOSCIENCES INC (AURA:NASDAQ) absolute price change since previous trading day?
The absolute price change of AURA BIOSCIENCES INC (AURA:NASDAQ) since the previous trading day is $-0.17.
AURA BIOSCIENCES INC (AURA:NASDAQ) percentage price change since previous trading day?
The percentage price change of AURA BIOSCIENCES INC (AURA:NASDAQ) since the previous trading day is -2.6357%.
What is the most recent average sentiment score for AURA BIOSCIENCES INC (AURA:NASDAQ)?
The most recent average sentiment score for AURA BIOSCIENCES INC (AURA:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for AURA BIOSCIENCES INC (AURA:NASDAQ)?
The most recent sentiment for AURA BIOSCIENCES INC (AURA:NASDAQ) is .
SEC-8K** Filing Available For AURA BIOSCIENCES INC (AURA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.